U.S. Markets closed

Belmond (BEL) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Belmond Ltd. BEL. The stock has moved higher by 31.8% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider BEL’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as BEL has earned itself a Zacks Rank #1 (Strong Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Belmond Ltd. (BEL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research